From April 11 to 15, we took part in ESCMID Global 2025 in Vienna, where TestLine Clinical Diagnostics s.r.o. independently represented the entire BioVendor Group for the first time, with a focus on MBA and CLIA technologies.

Unlike traditional trade fairs, ESCMID prioritized scientific value and direct interaction with clinical professionals. Our main goal was to deepen relationships with end users — laboratory specialists, diagnostic center leaders, and clinicians — rather than focus on commercial transactions.

At booth E86 in Hall B, together with our CLIA partner MIKROGEN GmbH, we showcased Microblot-Array multiplex diagnostics, CLIA solutions, and discussed the future of syndromic testing and automation.

Our team — Klára Hubačová, David Smékal, Michal Šteffl, and Jaromíra Nováková — welcomed visitors, demonstrated innovations, and engaged in meaningful technical conversations. The interactive atmosphere encouraged knowledge sharing and highlighted the importance of long-term partnerships based on scientific excellence.

We thank all our partners and visitors for their interest and look forward to the next ESCMID!